arxiv: 2604.19805 · v1 · submitted 2026-04-13 · 🧬 q-bio.PE

Recognition: unknown

Modeling of Pneumococcal and Respiratory Syncytial Virus Pneumonia: An Epidemiological Review, with Statistical Inference

Rupchand Sutradhar , Anuj Mishra , Malay Banerjee , Subhra Sankar Dhar

Authors on Pith no claims yet

Pith reviewed 2026-05-10 14:51 UTC · model grok-4.3

classification 🧬 q-bio.PE

keywords pneumonia modelingS. pneumoniaeRSVvaccine strategiesdeterministic modelsstochastic modelsepidemiological reviewimmunization planning

0 comments

The pith

Mathematical models for S. pneumoniae and RSV pneumonia show how vaccination programs can reduce global disease burden through better immunization planning.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

This review pulls together recent deterministic and stochastic models for two major causes of pneumonia: the bacterium Streptococcus pneumoniae and the respiratory syncytial virus. The authors examine how these models track transmission, measure vaccine performance, and describe population immunity levels. A reader would care because the models are used to test immunization strategies before they reach large populations and to forecast how many cases might be prevented. The paper argues that such modeling has become essential for guiding public health choices that aim to lower pneumonia deaths and hospitalizations worldwide. It synthesizes findings from multiple studies to point toward improved control of these vaccine-preventable illnesses.

Core claim

The paper claims that modeling has played a crucial role in assessing vaccine impacts and optimizing immunization strategies to minimize the disease burden for pneumonia caused by S. pneumoniae and RSV. It reviews both deterministic and stochastic models that capture disease transmission, vaccine efficacy, and population-level immunity, and it highlights their applications to these two pathogens.

What carries the argument

Deterministic and stochastic compartmental models that simulate transmission dynamics, vaccine effects, and immunity buildup across populations.

Load-bearing premise

The models reviewed in the paper accurately and comprehensively capture the real complexity of how these diseases spread, how well vaccines work, and how immunity behaves in populations.

What would settle it

Large-scale vaccination data showing actual reductions in pneumonia cases that differ markedly from the reductions predicted by the reviewed models would indicate that the models miss important real-world factors.

read the original abstract

Infectious diseases continue to pose significant public health challenges worldwide, requiring effective prevention and control strategies to mitigate their negative impact. Infectious diseases can be broadly classified into two groups: vaccine-preventable diseases (e.g., measles, polio, influenza, hepatitis B, pneumonia) and vaccine-non-preventable diseases (e.g., HIV/AIDS). Vaccine-preventable disease models are one of the essential tools for understanding infectious disease dynamics, evaluating intervention strategies, and guiding public health policies. In this review article, we explore the recent advancements in modeling two particular vaccine-preventable infectious diseases. Here, we consider both deterministic and stochastic models to comprehensively capture the complexity of disease transmission, vaccine efficacy, and population-level immunity. We highlight the application of these models to the infectious diseases, namely, bacterial and viral pneumonia caused by the bacteria Streptococcus pneumoniae (S. pneumoniae) and the respiratory syncytial virus (RSV). Pneumonia carry a substantial global burden, where modeling has played a crucial role in assessing vaccine impacts and optimizing immunization strategies to minimize the disease burden. By synthesizing recent methodologies and findings, this review provides valuable insights for future research and policy decisions aimed at improving vaccine-preventable disease control for pneumonia caused by S. pneumoniae and RSV.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Desk Editor's Note private letter to a colleague

This is a review that organizes existing models for pneumococcal and RSV pneumonia but adds no new results or analyses.

read the letter

This paper is a review article that synthesizes existing deterministic and stochastic models for pneumonia caused by Streptococcus pneumoniae and respiratory syncytial virus. It does not introduce any new models, data, or statistical inferences. The authors do a good job of highlighting how these models have been used to assess vaccine impacts and optimize immunization strategies for these two diseases. They correctly note the substantial global burden of pneumonia and the role modeling plays in public health decisions. The focus on both bacterial and viral causes allows for some comparison of approaches to transmission, efficacy, and immunity. What works here is the clear organization of recent methodologies from the literature. For someone looking for an overview of how modeling informs policy on vaccine-preventable respiratory diseases, this could be a convenient reference. The soft spots are typical for a review without original work. There is no new analysis or critique that advances understanding beyond what the cited papers already provide. The abstract lacks details on study selection or how limitations in the underlying models were addressed, so the full manuscript must show thorough and balanced coverage to be truly useful. Without that, it stays at the level of summary. No technical vulnerabilities stand out because the paper does not derive or fit anything itself. The claims rest on the external literature. This paper is for readers who want a consolidated introduction to modeling work on these specific infections, such as students, policymakers, or researchers branching into the area. It is unlikely to provide new insights for those already deep in infectious disease modeling. It deserves a serious referee. Review papers on important public health topics can be worthwhile if they accurately capture the state of the field. I would recommend sending it to peer review, asking referees to check the completeness and fairness of the synthesis.

Referee Report

2 major / 3 minor

Summary. The manuscript is a review article examining recent advancements in deterministic and stochastic modeling of two vaccine-preventable diseases: bacterial pneumonia caused by Streptococcus pneumoniae and viral pneumonia caused by respiratory syncytial virus (RSV). It synthesizes methodologies and findings from the existing literature to highlight how these models have been applied to assess vaccine impacts, optimize immunization strategies, and inform public health policies aimed at reducing the global burden of pneumonia.

Significance. If the synthesis faithfully represents the cited models and their applications, the review could provide a useful consolidation of knowledge on epidemiological modeling for S. pneumoniae and RSV, potentially aiding researchers and policymakers. The explicit coverage of both deterministic and stochastic frameworks is a strength, as is the focus on vaccine-preventable aspects. However, the significance is limited by the absence of new analyses, quantitative comparisons, or original statistical inferences, making the contribution primarily organizational rather than generative.

major comments (2)

The title includes the phrase 'with Statistical Inference,' yet the abstract and overall framing describe only a literature synthesis without any original statistical analyses, parameter estimations, or inferences performed by the authors. This mismatch is load-bearing for reader expectations about the paper's scope and contributions.
Abstract: The statement that the models 'comprehensively capture the complexity of disease transmission, vaccine efficacy, and population-level immunity' is presented without accompanying critique of key limitations in the reviewed deterministic and stochastic models (e.g., assumptions of homogeneous mixing or data quality issues), which weakens support for the claim that the review provides 'valuable insights' for policy.

minor comments (3)

The abstract would be strengthened by including one or two concrete examples of specific models or key quantitative findings from the cited literature rather than remaining at a high level of generality.
Clarify the criteria used for selecting the studies and models discussed, as this is essential for evaluating the completeness of the synthesis in a review paper.
Ensure that terminology for the pathogens (S. pneumoniae vs. pneumococcal) and diseases is used consistently to avoid potential confusion for readers.

Simulated Author's Rebuttal

2 responses · 0 unresolved

We thank the referee for their constructive feedback and positive view of the manuscript's potential to consolidate knowledge on epidemiological modeling for S. pneumoniae and RSV. We address the major comments point by point below, with revisions planned where appropriate to improve clarity and balance.

read point-by-point responses

Referee: The title includes the phrase 'with Statistical Inference,' yet the abstract and overall framing describe only a literature synthesis without any original statistical analyses, parameter estimations, or inferences performed by the authors. This mismatch is load-bearing for reader expectations about the paper's scope and contributions.

Authors: We acknowledge that the title phrase 'with Statistical Inference' could reasonably lead readers to expect original analyses by the authors, which the manuscript does not contain. The phrase was intended to signal that the review synthesizes models employing statistical inference methods from the literature. To eliminate any ambiguity and align the title precisely with the review's scope, we will revise the title to 'Modeling of Pneumococcal and Respiratory Syncytial Virus Pneumonia: An Epidemiological Review' in the next version. revision: yes
Referee: Abstract: The statement that the models 'comprehensively capture the complexity of disease transmission, vaccine efficacy, and population-level immunity' is presented without accompanying critique of key limitations in the reviewed deterministic and stochastic models (e.g., assumptions of homogeneous mixing or data quality issues), which weakens support for the claim that the review provides 'valuable insights' for policy.

Authors: We agree that a review claiming to provide valuable insights should explicitly address model limitations to maintain balance and credibility. The current abstract uses strong language without sufficient qualification. In the revised manuscript, we will temper the abstract wording and add a concise discussion of key limitations of the reviewed models, including homogeneous mixing assumptions in deterministic frameworks and issues of data quality and parameter uncertainty in stochastic approaches. This addition will strengthen the policy-relevant insights by presenting a more nuanced synthesis. revision: yes

Circularity Check

0 steps flagged

No significant circularity identified

full rationale

This is a literature review paper that synthesizes methodologies and findings from prior external studies on deterministic and stochastic models for S. pneumoniae and RSV pneumonia. No new equations, parameter estimations, predictions, or derivations are advanced by the authors themselves. All load-bearing claims rest on citations to independent prior work rather than any self-referential fitting, self-definition, or self-citation chain internal to this manuscript. The derivation chain is therefore self-contained against external benchmarks with no reduction to the paper's own inputs.

Axiom & Free-Parameter Ledger

0 free parameters · 0 axioms · 0 invented entities

As a review paper, the central claims rest on the accuracy and representativeness of the cited literature rather than new axioms, parameters, or entities introduced here.

pith-pipeline@v0.9.0 · 5539 in / 1032 out tokens · 30507 ms · 2026-05-10T14:51:25.666548+00:00 · methodology

discussion (0)

Reference graph

Works this paper leans on

147 extracted references · 7 canonical work pages

[1]

Pneumonia

World Health Organization. Pneumonia. Available at:. https://www.who.int/news-room/ fact-sheets/detail/pneumonia. 2025

2025
[2]

Vaccines10(5), 714 (2022)

Trombetta, C.M., Kistner, O., Montomoli, E., Viviani, S., Marchi, S.: Influenza viruses and vaccines: the role of vaccine effectiveness studies for evaluation of the benefits of influenza vaccines. Vaccines10(5), 714 (2022)

2022
[3]

Medical science monitor: international medical journal of experimental and clinical research30, 944436–1 (2024)

Parums, D.V.: A review of the resurgence of measles, a vaccine-preventable disease, as cur- rent concerns contrast with past hopes for measles elimination. Medical science monitor: international medical journal of experimental and clinical research30, 944436–1 (2024)

2024
[4]

The lancet385(9966), 430–440 (2015)

Liu, L., Oza, S., Hogan, D., Perin, J., Rudan, I., Lawn, J.E., Cousens, S., Mathers, C., Black, R.E.: Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. The lancet385(9966), 430–440 (2015)

2000
[5]

Vaccines12(3), 288 (2024) 16

Al-Busafi, S.A., Alwassief, A.: Global perspectives on the hepatitis B vaccination: challenges, achievements, and the road to elimination by 2030. Vaccines12(3), 288 (2024) 16

2030
[6]

Medicines For Women, 271–289 (2014)

Stanley, M.: Human papilloma virus vaccines. Medicines For Women, 271–289 (2014)

2014
[7]

The Lancet374(9693), 893–902 (2009)

O’brien, K.L., Wolfson, L.J., Watt, J.P., Henkle, E., Deloria-Knoll, M., McCall, N., Lee, E., Mul- holland, K., Levine, O.S., Cherian, T.: Burden of disease caused by streptococcus pneumoniae in children younger than 5 years: global estimates. The Lancet374(9693), 893–902 (2009)

2009
[8]

The Lancet375(9725), 1545–1555 (2010)

Nair, H., Nokes, D.J., Gessner, B.D., Dherani, M., Madhi, S.A., Singleton, R.J., O’Brien, K.L., Roca, A., Wright, P.F., Bruce, N.,et al.: Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. The Lancet375(9725), 1545–1555 (2010)

2010
[9]

In: Seminars in Respiratory and Critical Care Medicine, vol

Feldman, C., Anderson, R.: The role of streptococcus pneumoniae in community-acquired pneumonia. In: Seminars in Respiratory and Critical Care Medicine, vol. 37, pp. 806–818 (2016)

2016
[10]

Frontiers in immunology9, 1366 (2018)

Brooks, L.R., Mias, G.I.: Streptococcus pneumoniae’s virulence and host immunity: aging, diagnostics, and prevention. Frontiers in immunology9, 1366 (2018)

2018
[11]

Weiser, J.N., Ferreira, D.M., Paton, J.C.: Streptococcus pneumoniae: transmission, colonization and invasion. Nat. Rev. Microbiol.16(6), 355–367 (2018)

2018
[12]

Trends in microbiol.21(3), 129–135 (2013)

Shak, J.R., Vidal, J.E., Klugman, K.P.: Influence of bacterial interactions on pneumococcal colonization of the nasopharynx. Trends in microbiol.21(3), 129–135 (2013)

2013
[13]

Lancet Infect

Bogaert, D., De Groot, R., Hermans, P.: Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect. Dis.4(3), 144–154 (2004)

2004
[14]

The Lancet374(9700), 1543–1556 (2009)

Poll, T., Opal, S.M.: Pathogenesis, treatment, and prevention of pneumococcal pneumonia. The Lancet374(9700), 1543–1556 (2009)

2009
[15]

Dustin: Pneumococcal vaccination effectiveness (PCV13 and PPSV23) in individuals with and without reduced kidney function: a test-negative design study

Le, e.a. Dustin: Pneumococcal vaccination effectiveness (PCV13 and PPSV23) in individuals with and without reduced kidney function: a test-negative design study. Clin. Kidney J.17, 107977 (2024)

2024
[16]

Wp, H.: Which pneumococcal serogroups cause the most invasive disease: Implications for conjugate vaccine formulation and use, part I. Clin. Infect. Dis.30, 100–121 (2000)

2000
[17]

The Lancet378(9807), 1962–1973 (2011)

Weinberger, D.M., Malley, R., Lipsitch, M.: Serotype replacement in disease after pneumococcal vaccination. The Lancet378(9807), 1962–1973 (2011)

1962
[18]

Klugman, K.P.: Contribution of vaccines to our understanding of pneumococcal disease. Philos. Trans. R. Soc. Lond. B Biol. Sci.366(1579), 2790–2798 (2011)

2011
[19]

Lancet Glob

Wahl, B., O’Brien, K.L., Greenbaum, A., Majumder, A., Liu, L., Chu, Y., Lukˇ si´ c, I., Nair, H., McAllister, D.A., Campbell, H.,et al.: Burden of streptococcus pneumoniae and haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15. Lancet Glob. Health6(7), 744–757 (2018)

2000
[20]

https://www.who.int/news-room/ fact-sheets/detail/respiratory-syncytial-virus-(rsv)

Data, O.W.: Respiratory syncytial virus (25 March 2025). https://www.who.int/news-room/ fact-sheets/detail/respiratory-syncytial-virus-(rsv)

2025
[21]

Nuttens, C., Moyersoen, J., Curcio, D., Aponte-Torres, Z., Baay, M., Vroling, H., Gessner, B.D., Begier, E.: Differences between RSV A and RSV B subgroups and implications for pharmaceutical preventive measures. Infect. Dis. Ther.13(8), 1725–1742 (2024)

2024
[22]

CB, H.: The burden of respiratory syncytial virus infection in young children. N. Engl. J. Med. 360, 588–598 (2009)

2009
[23]

https://www.cdc.gov/rsv/ causes/index.html

Centers for Disease Control and Prevention: How RSV Spreads. https://www.cdc.gov/rsv/ causes/index.html
[24]

Shi, e.a. Ting: Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. The Lancet390, 946–958 (2017)

2015
[25]

Chatterjee, A., Mavunda, K., Krilov, L.R.: Current state of respiratory syncytial virus disease 17 and management. Infect. Dis. Ther.10, 5–16 (2021)

2021
[26]

Cureus15(3) (2023)

Kaler, J., Hussain, A., Patel, K., Hernandez, T., Ray, S.: Respiratory syncytial virus: a comprehensive review of transmission, pathophysiology, and manifestation. Cureus15(3) (2023)

2023
[27]

Cleo: Development, current status, and remaining challenges for respira- tory syncytial virus vaccines

Anastassopoulou, e.a. Cleo: Development, current status, and remaining challenges for respira- tory syncytial virus vaccines. Vaccines2, 97 (2025)

2025
[28]

Falsey, A.R., Hennessey, P.A., Formica, M.A., Cox, C., Walsh, E.E.: Respiratory syncytial virus infection in elderly and high-risk adults. N. Engl. J. Med.352(17), 1749–1759 (2005)

2005
[29]

Chan, M., Park, J.J., Shi, T., Martin´ on–Torres, F., Bont, L., Nair, H., Network, R.S.V.: The burden of respiratory syncytial virus (RSV) associated acute lower respiratory infections in children with down syndrome: A systematic review and meta–analysis. J. Glob. Health7(2), 020413 (2017)

2017
[30]

The Lancet378(9807), 1917–1930 (2011)

Nair, H., Brooks, W.A., Katz, M., Roca, A., Berkley, J.A., Madhi, S.A., Simmerman, J.M., Gordon, A., Sato, M., Howie, S.,et al.: Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. The Lancet378(9807), 1917–1930 (2011)

1917
[31]

Lancet Infect Dis.18(11), 1191–1210 (2018)

Troeger, C., Blacker, B., Khalil, I.A., Rao, P.C., Cao, J., Zimsen, S.R., Albertson, S.B., Desh- pande, A., Farag, T., Abebe, Z.,et al.: Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a system- atic analysis for the global burden of disease study 2016. Lanc...

1990
[32]

Devakumar, D., Uthayakumar-Cumarasamy, A., Nielsen, M., Sousa, P., Stinchcombe, B.: Im- pact of the covid-19 pandemic on global child health: joint statement of the international child health group and the royal college of paediatrics and child health (2020)

2020
[33]

Respiratory Medicine234, 107828 (2024)

Zhou, T., Chen, D., Chen, Q., Jin, X., Su, M., Zhang, H., Tian, L., Wen, S., Zhong, L., Ma, Y.,et al.: The impact of the covid-19 pandemic on RSV outbreaks in children: A multicenter study from china. Respiratory Medicine234, 107828 (2024)

2024
[34]

Mathematics Open03(2024)

Mumbu, A.: Modeling dynamics and stability analysis of pneumonia disease infection with parameters uncertainties control. Mathematics Open03(2024)

2024
[35]

Princeton university press, Princeton (2008)

Keeling, M.J., Rohani, P.: Modeling Infectious Diseases in Humans and Animals. Princeton university press, Princeton (2008)

2008
[36]

SIAM review 41(1), 3–44 (1999)

Perelson, A.S., Nelson, P.W.: Mathematical analysis of HIV-1 dynamics in vivo. SIAM review 41(1), 3–44 (1999)

1999
[37]

Nature507(7490), 57–61 (2014)

Luksza, M., L¨ assig, M.: A predictive fitness model for influenza. Nature507(7490), 57–61 (2014)

2014
[38]

Teklu, S.W., Kotola, B.S.: Mathematical model and backward bifurcation analysis of pneumonia infection with intervention measures. Res. math.11(1) (2024)

2024
[39]

Partial Differ

Purohit, S.,et al.: A novel study of the impact of vaccination on pneumonia via fractional approach. Partial Differ. Equ. Appl. Math.10, 100698 (2024)

2024
[40]

Reicherz, F., Xu, R.Y., Abu-Raya, B., Majdoubi, A., Michalski, C., Golding, L., Stojic, A., Vineta, M., Granoski, M., Cieslak, Z.,et al.: Waning immunity against respiratory syncytial virus during the coronavirus disease 2019 pandemic. J. Infect. Dis.226(12), 2064–2068 (2022)

2019
[41]

PLoS ONE3(9), 3244 (2008)

Temime, L., Boelle, P.-Y., Opatowski, L., Guillemot, D.: Impact of capsular switch on invasive pneumococcal disease incidence in a vaccinated population. PLoS ONE3(9), 3244 (2008)

2008
[42]

Otieno, M.J.O.J., Paul, O.: Mathematical model for pneumonia dynamics with carriers. Int. Journal of Math. Analysis7, 2457–2473 (2013)

2013
[43]

PloS ONE9(6), 100422 (2014) 18

Moore, H.C., Jacoby, P., Hogan, A.B., Blyth, C.C., Mercer, G.N.: Modelling the seasonal epidemics of respiratory syncytial virus in young children. PloS ONE9(6), 100422 (2014) 18

2014
[44]

BMC Infect

Leecaster, M., Gesteland, P., Greene, T., Walton, N., Gundlapalli, A., Rolfs, R., Byington, C., Samore, M.: Modeling the variations in pediatric respiratory syncytial virus seasonal epidemics. BMC Infect. Dis.11(1), 105 (2011)

2011
[45]

Scientific reports 5(1), 11344 (2015)

Numminen, E., Chewapreecha, C., Turner, C., Goldblatt, D., Nosten, F., Bentley, S.D., Turner, P., Corander, J.: Climate induces seasonality in pneumococcal transmission. Scientific reports 5(1), 11344 (2015)

2015
[46]

Cell` es, M., Arduin, H., L´ evy-Bruhl, D., Georges, S., Souty, C., Guillemot, D., Watier, L., Opatowski, L.: Unraveling the seasonal epidemiology of pneumococcus. Proc. Natl. Acad. Sci. 116(5), 1802–1807 (2019)

2019
[47]

Weinberger, D.M., Grant, L.R., Steiner, C.A., Weatherholtz, R., Santosham, M., Viboud, C., O’Brien, K.L.: Seasonal drivers of pneumococcal disease incidence: impact of bacterial carriage and viral activity. Clin. Infect. Dis.58(2), 188–194 (2014)

2014
[48]

Scientific reports11(1), 20422 (2021)

Wangdi, K., Penjor, K., Tsheten, T., Tshering, C., Gething, P., Gray, D.J., Clements, A.C.: Spatio-temporal patterns of childhood pneumonia in Bhutan: A Bayesian analysis. Scientific reports11(1), 20422 (2021)

2021
[49]

In: Open Forum Infectious Diseases, vol

Liang, J., Luz, S., Li, Y., Nair, H.: Associations between environmental conditions and infec- tion with Respiratory Syncytial Virus in Japan: A spatiotemporal analysis. In: Open Forum Infectious Diseases, vol. 12, p. 392 (2025). Oxford University Press US

2025
[50]

BMC pediatrics25(1), 182 (2025)

Degif, K.A., Gebrehiwot, M., Tadege, G., Demoze, L., Yitageasu, G.: Spatial and temporal variation of pneumonia incidence among under-five children in central gondar zone, Northwest Ethiopia, 2013-2022. BMC pediatrics25(1), 182 (2025)

2013
[51]

Swai, M.C., Shaban, N., Marijani, T.: Optimal control in two strain pneumonia transmission dynamics. J. Appl. Math.2021(1), 8835918 (2021)

2021
[52]

Chukwu, C.W., Tchoumi, S.Y., Diagne, M.L.: A simulation study to assess the epidemiological impact of pneumonia transmission dynamics in high-risk populations. Decis. Anal. J.10, 100423 (2024)

2024
[53]

Mathematical Theory and Modeling5(10), 21–39 (2015)

Ndelwa, E., Kgosimore, M., Massawe, E., Namkinga, L.: Mathematical modelling and analysis of treatment and screening of pneumonia. Mathematical Theory and Modeling5(10), 21–39 (2015)

2015
[54]

Tilahun, G.T., Makinde, O.D., Malonza, D.: Modelling and optimal control of pneumonia disease with cost-effective strategies. J. Biol. Dyn.11, 400–426 (2017)

2017
[55]

Kizito, M., Tumwiine, J.: A mathematical model of treatment and vaccination interventions of pneumococcal pneumonia infection dynamics. J. Appl. Math.2018(1), 2539465 (2018)

2018
[56]

Zephaniah, O.C., Nwaugonma, U.-I.R., Chioma, I.S., Adrew, O.: A mathematical model and analysis of an sveir model for streptococcus pneumonia with saturated incidence force of infection. Math. Model. Appl.5(1), 16–38 (2020)

2020
[57]

In: AIP Conference Proceedings, vol

Alya, J., Aldila, D., Rusin, R.: A mathematical model of the spread of pneumococcal pneumonia disease by considering vaccine and hospital care interventions. In: AIP Conference Proceedings, vol. 2498 (2022). AIP Publishing

2022
[58]

Mochan, E., Swigon, D., Ermentrout, G.B., Lukens, S., Clermont, G.: A mathematical model of intrahost pneumococcal pneumonia infection dynamics in murine strains. J. Theor. Biol.353, 44–54 (2014)

2014
[59]

Abdullah Hasan Hassan, Kamalia, P.Z.: An analytical transmission model for evaluating pneumonia vaccination and control strategies

Dipo Aldila, M.H.N.A. Abdullah Hasan Hassan, Kamalia, P.Z.: An analytical transmission model for evaluating pneumonia vaccination and control strategies. Healthcare Analytics7, 100394 (2025)

2025
[60]

Scientific Reports12(1), 2639 (2022) 19

Kotola, B.S., Mekonnen, T.T.: Mathematical model analysis and numerical simulation for co- dynamics of meningitis and pneumonia infection with intervention. Scientific Reports12(1), 2639 (2022) 19

2022
[61]

Greenhalgh, D., Lamb, K.E., Robertson, C.: A mathematical model for the spread of strepo- tococcus pneumoniae with transmission dependent on serotype. J. Biol. Dyn.6(sup1), 72–87 (2012)

2012
[62]

Epidemics27, 1–11 (2019)

Kombe, I.K., Munywoki, P.K., Baguelin, M., Nokes, D.J., Medley, G.F.: Model-based estimates of transmission of respiratory syncytial virus within households. Epidemics27, 1–11 (2019)

2019
[63]

BMC medicine18(1), 348 (2020)

Hodgson, D., Pebody, R., Panovska-Griffiths, J., Baguelin, M., Atkins, K.E.: Evaluating the next generation of RSV intervention strategies: a mathematical modelling study and cost-effectiveness analysis. BMC medicine18(1), 348 (2020)

2020
[64]

Vaccine: X4, 100055 (2020)

Kinyanjui, T., Pan-Ngum, W., Saralamba, S., Taylor, S., White, L., Nokes, D.J.: Model evalu- ation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting. Vaccine: X4, 100055 (2020)

2020
[65]

Vaccine35(2), 403–409 (2017)

Pan-Ngum, W., Kinyanjui, T., Kiti, M., Taylor, S., Toussaint, J.-F., Saralamba, S., Van Effel- terre, T., Nokes, D.J., White, L.J.: Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach. Vaccine35(2), 403–409 (2017)

2017
[66]

White, L., Poovorawan, K., Soonthornworasiri, N., Sukontamarn, P., Chanthav- ilay, P., F

Mahikul, W., J. White, L., Poovorawan, K., Soonthornworasiri, N., Sukontamarn, P., Chanthav- ilay, P., F. Medley, G., Pan-Ngum, W.: Modeling household dynamics on respiratory syncytial virus (RSV). PLoS ONE14(7), 0219323 (2019)

2019
[67]

Arenas, A.J., Gonz´ alez, G., J´ odar, L.: Existence of periodic solutions in a model of respiratory syncytial virus RSV. J. Math. Anal. Appl.344(2), 969–980 (2008)

2008
[68]

Vaccine38(2), 251–257 (2020)

Rainisch, G., Adhikari, B., Meltzer, M.I., Langley, G.: Estimating the impact of multiple immu- nization products on medically-attended respiratory syncytial virus (RSV) infections in infants. Vaccine38(2), 251–257 (2020)

2020
[69]

Medical decision making32(5), 712–721 (2012)

Pitman, R., Fisman, D., Zaric, G.S., Postma, M., Kretzschmar, M., Edmunds, J., Brisson, M.: Dynamic transmission modeling: a report of the ISPOR-SMDM modeling good research practices task force working group–5. Medical decision making32(5), 712–721 (2012)

2012
[70]

Oxford university press, Oxford (1991)

Anderson, R.M., May, R.M.: Infectious Diseases of Humans: Dynamics and Control. Oxford university press, Oxford (1991)

1991
[71]

Diekmann, O., Heesterbeek, H., Britton, T.: Mathematical Tools for Understanding Infectious Disease Dynamics vol. 7. Princeton University Press, Princeton (2013)

2013
[72]

Oidtman, R.J., Meleleo, G., Sharomi, O., Matthews, I.R., Ntais, D., Nachbar, R.B., Malik, T.M., Bakker, K.M.: Modelling the epidemiological impact of different adult pneumococcal vaccination strategies in the United Kingdom. Infect. Dis. Ther.14(3), 587–602 (2025)

2025
[73]

Available at:

Ourworldindata, Pneumonia. Available at:. https://ourworldindata.org/pneumonia. February, 2024

2024
[74]

Respiratory medicine137, 6–13 (2018)

Torres, A., Cill´ oniz, C., Blasi, F., Chalmers, J.D., Gaillat, J., Dartois, N., Schmitt, H.-J., Welte, T.: Burden of pneumococcal community-acquired pneumonia in adults across europe: a literature review. Respiratory medicine137, 6–13 (2018)

2018
[75]

Munn, Z., Peters, M.D., Stern, C., Tufanaru, C., McArthur, A., Aromataris, E.: Systematic review or scoping review? guidance for authors when choosing between a systematic or scoping review approach. BMC Med. Res. Methodol.18(1), 143 (2018)

2018
[76]

PLoS medicine16(7), 1002845 (2019)

Choi, Y.H., Andrews, N., Miller, E.: Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+ 1 to 1+ 1 in England and Wales: a modelling study. PLoS medicine16(7), 1002845 (2019)

2019
[77]

Vaccines13(3), 304 (2025) 20

Deng, L., Cao, H., Li, G., Zhou, K., Fu, Z., Zhong, J., Wang, Z., Yang, X.: Progress on res- piratory syncytial virus vaccine development and evaluation methods. Vaccines13(3), 304 (2025) 20

2025
[78]

Daniels, C.C., Rogers, P.D., Shelton, C.M.: A review of pneumococcal vaccines: current polysac- charide vaccine recommendations and future protein antigens. J. Pediatr. Pharmacol. Ther. 21(1), 27–35 (2016)

2016
[79]

Korean journal of pediatrics57(2), 55 (2014)

Lee, H., Choi, E.H., Lee, H.J.: Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines. Korean journal of pediatrics57(2), 55 (2014)

2014
[80]

Korean J

Choi, E.H., Kim, K.H., Kim, Y.J., Kim, J.H., Park, S.E., Lee, H.J., Eun, B.W., Jo, D.S., Choi, K.M., Hong, Y.J.: Recommendation for use of the newly introduced pneumococcal protein conjugate vaccines in korea. Korean J. Pediatr.54(4), 146 (2011)

2011

Showing first 80 references.